Clindamycin 3,4-Dipalmitate - Request Quote
Clindamycin 3,4-Dipalmitate
| SZ CAT No: | SZ-C076095 |
| CAS No | NA |
| Mol.F. | C50H93ClN2O7S |
| Mol.Wt. | 901.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Clindamycin 3,4-Dipalmitate is chemically (2R,3S,4R,5R,6R)-2-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-5-hydroxy-6-(methylthio)tetrahydro-2H-pyran-3,4-diyl dipalmitate. Clindamycin 3,4-Dipalmitate is supplied with detailed characterization data compliant with regulatory guideline. Clindamycin 3,4-Dipalmitate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clindamycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Clindamycin 3,4-Dipalmitate
Purchase Clindamycin 3,4-Dipalmitate
Clindamycin 3,4-Dipalmitate suppliers
Clindamycin 3,4-Dipalmitate manufacturers
Clindamycin 3,4-Dipalmitate price
Order Clindamycin 3,4-Dipalmitate
Enquire Clindamycin 3,4-Dipalmitate
Clindamycin 3,4-Dipalmitate cost
Clindamycin 3,4-Dipalmitate Supplier
Clindamycin 3,4-Dipalmitate Distributor
Clindamycin 3,4-Dipalmitate for Method Validation
Clindamycin Reference Standard
Clindamycin 3,4-Dipalmitate for ANDA Filing
Clindamycin 3,4-Dipalmitate for Forced Degradation Studies
Clindamycin 3,4-Dipalmitate Identification Standards
Clindamycin 3,4-Dipalmitate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.